دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 12,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
قیمت : 4,000,000 تومان- قیمت ویژه : 1,750,000تومان
BASAL LAMINAR DEPOSITS AND PSEUDODRUSEN: Rethinking Their Role in Age-Related Macular Degeneration Progression.
doi : 10.1097/IAE.0000000000004683
Volume 46(3) pgs. 399-556,e17-e27 March 2026
OUTER RETINAL LAYER DETERIORATION PATTERNS IN EYES WITH DIABETIC SEROUS MACULAR DETACHMENT.
ASSOCIATION OF PATIENT AGE WITH RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS FOR TREATMENT OF DIABETIC MACULAR EDEMA.
EXPANDED FIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY BIOMARKERS ASSOCIATED WITH FUTURE CARDIOVASCULAR DISEASE AND MORTALITY IN PATIENTS WITH DIABETIC RETINOPATHY.
CLINICAL AND MICROBIOLOGICAL CHARACTERISTICS OF MULTIDRUG-RESISTANT ACUTE BACTERIAL ENDOPHTHALMITIS AFTER CATARACT SURGERY: Endophthalmitis Management Study Report 8.
ROLE OF INFLAMMATION IN ATROPHY DEVELOPMENT AND PROGRESSION IN PATHOLOGIC MYOPIA.
THE IMPACT OF POSTERIOR STAPHYLOMA ON CLINICAL OUTCOMES OF HIGH MYOPIC MACULAR HOLE: A Retrospective Cohort Study.
CHOROIDAL VASCULARITY INDEX, RETINAL VASCULARITY, AND HEMOGLOBIN LEVELS IN PEDIATRIC SICKLE CELL MACULOPATHY.
OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY BIOMARKERS FOR PREDICTING RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
CORRELATION OF RETINAL IMAGING UTILIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AND PANRETINAL PHOTOCOAGULATION USAGE FROM 2013 TO 2021.
DIAGNOSTIC PERFORMANCE OF MACHINE LEARNING TECHNOLOGY USING OPTICAL COHERENCE TOMOGRAPHIC IMAGE IN RETINAL DISEASES PRESENTED WITH SUBRETINAL FLUID.
EARLY FINDINGS FROM A NATURAL HISTORY STUDY OF PATIENTS WITH THE PATHOGENIC p.Gly208Asp PRPH2 VARIANT ASSOCIATED WITH RETINAL DYSTROPHY.
EFFICACY AND VASCULAR REDEVELOPMENT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGE 2 EARLY-DIAGNOSED FAMILIAL EXUDATIVE VITREORETINOPATHY.
A NOVEL TECHNIQUE FOR SUBRETINAL HEMATOMA MIGRATION: Directing the Lesion Toward Artificial Retinal Detachment.
